1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Cohort profile : the European Unified Registries On Heart Care Evaluation and Randomized Trials (EuroHeart)—acute coronary syndrome and percutaneous coronary intervention
(
- Contribution to journal › Article
- 2023
-
Mark
European practice patterns for antiplatelet management in NSTE-ACS patients : Results from the REal-world ADoption survey focus on Acute antiPlatelet Treatment (READAPT) survey
(
- Contribution to journal › Article
-
Mark
Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes
(
- Contribution to journal › Article
-
Mark
European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology
(
- Contribution to journal › Article
- 2022
-
Mark
Data standards for acute coronary syndrome and percutaneous coronary intervention : the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)
(
- Contribution to journal › Article
-
Mark
European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes
(
- Contribution to journal › Scientific review
-
Mark
Development and validation of an artificial neural network algorithm to predict mortality and admission to hospital for heart failure after myocardial infarction : a nationwide population-based study
(
- Contribution to journal › Article
-
Mark
Safety of early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention : A nationwide cohort study
(
- Contribution to journal › Article
- 2021
-
Mark
Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT) : Rationale and design: MINOCA-BAT: Rationale and design
(
- Contribution to journal › Article
- 2018
-
Mark
Registry-based randomised clinical trial : Efficient evaluation of generic pharmacotherapies in the contemporary era
(
- Contribution to journal › Article